Copyright
©The Author(s) 2016.
World J Gastroenterol. Dec 7, 2016; 22(45): 10015-10023
Published online Dec 7, 2016. doi: 10.3748/wjg.v22.i45.10015
Published online Dec 7, 2016. doi: 10.3748/wjg.v22.i45.10015
Extremely low plus low risk (n = 28) | Intermediate risk(n = 3) | High risk (n = 3) | Total (n = 34) | |
Follow-up period, median (range), mo | 31.0 (6.6-210) | 47.3 (11.2-49.9) | 12.4 (7.4-16.7) | 27.3 (6.6-210) |
Initial tumor diameter, median (range), mm | 18.6 (10.9-30.0) | 28.5 (20.0-44.8) | 25.5 (14.0-27.3) | 19.0 (10.9-44.8) |
Doubling time, median (range), mo | 24.0 (2.0-183.6) | 17.1 (6.1-19.4) | 3.9 (0.8-10.4) | 17.2 (0.8-183.6) |
- Citation: Koizumi S, Kida M, Yamauchi H, Okuwaki K, Iwai T, Miyazawa S, Takezawa M, Imaizumi H, Koizumi W. Clinical implications of doubling time of gastrointestinal submucosal tumors. World J Gastroenterol 2016; 22(45): 10015-10023
- URL: https://www.wjgnet.com/1007-9327/full/v22/i45/10015.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i45.10015